Lozapin 50mg Tablet contains Clozapine, an atypical antipsychotic agent primarily indicated for the treatment of schizophrenia, particularly in patients who are resistant to standard antipsychotic therapies. Clozapine exerts its therapeutic effects by modulating various neurotransmitter receptors in the brain, including dopamine D2 and serotonin 5-HT2A receptors, which helps alleviate both positive and negative symptoms of schizophrenia. This medication is also utilized to reduce the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder. Lozapin should be administered under strict medical supervision due to its potential for serious adverse effects, including agranulocytosis, seizures, myocarditis, and orthostatic hypotension. Regular monitoring of white blood cell counts and absolute neutrophil counts is mandatory before and during treatment to detect hematological abnormalities early. Dosage should be individualized based on patient response and tolerability, with gradual titration to minimize side effects such as sedation, hypersalivation, and weight gain. Clozapine is contraindicated in patients with a history of clozapine-induced agranulocytosis or severe cardiac conditions. Patients should be advised to report any signs of infection, fever, or unusual fatigue promptly. Lozapin 50mg Tablet offers a valuable therapeutic option for refractory schizophrenia when used with appropriate clinical oversight.